Pathogenic organisms in hip joint infections

International Journal of Medical Sciences

Volumn 6, Issue 5, 2009, Pages 234-240

  Geipel, Udo ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Arthritis; Bacteria; Diagnosis; Prosthesis; Therapy

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; C REACTIVE PROTEIN; CEFAZOLIN; CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; FLUCLOXACILLIN; GLYCOPEPTIDE; HLA B27 ANTIGEN; IMIPENEM; LINEZOLID; METRONIDAZOLE; NAFCILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BARTONELLA HENSELAE; BIOFILM; BORRELIA BURGDORFERI; BRUCELLA; CAMPYLOBACTER; CHLAMYDIA TRACHOMATIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COXITIS; ECONOMIC ASPECT; ESCHERICHIA COLI; HISTOPATHOLOGY; HUMAN; INFECTIOUS ARTHRITIS; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA PNEUMONIAE; NEISSERIA GONORRHOEAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; REIMPLANTATION; REVIEW; SALMONELLA ENTERICA; SERODIAGNOSIS; SHIGELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TISSUE DISTRIBUTION; TROPHERYMA WHIPPELII; UREAPLASMA UREALYTICUM; YERSINIA;

EID: 70349899081     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.6.234     Document Type: Review

References (24)

1. Kaandorp CJ, Krijnen P, Moens HJ, Habbema JD, van Schaardenburg D. The outcome of bacterial arthritis: a prospective community-based study. Arthritis Rheum. 1997; 40: 884-892 (Pubitemid 27200005)
2. Kaandorp CJ, van Schaardenburg D, Krijnen P, Habbema JD, van de Laar MA. Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis Rheum. 1995; 38: 1819-1825
3. Shirtliff ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev. 2002; 15: 527-544
4. Herrmann M, Vaudaux PE, Pittet D, Auckenthaler R, Lew PD, Schumacher-Perdreau F, Peters G, Waldvogel FA. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis. 1988; 158: 693-701. (Pubitemid 18252002)
5. McGavin MH, Krajewska-Pietrasik D, Rydén C, Höök M. Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity. Infect Immun. 1993; 61: 2479-2485 (Pubitemid 23159238)
6. Lopes JD, dos Reis M, Brentani RR. Presence of laminin receptors in Staphylococcus aureus. Science. 1985; 229: 275-277
7. Switalski LM, Patti JM, Butcher W, Gristina AG, Speziale P, Höök M. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol Microbiol. 1993; 7: 99-107. (Pubitemid 23011100)
8. Brause BD. Infections associated with prosthetic joints. Clin Rheum Dis. 1986; 12: 523-536
9. Sendi P, Rohrbach M, Graber P, Frei R, Ochsner PE, Zimmerli W. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis. 2006; 43: 961-967 (Pubitemid 44631093)
10. Roisman, FR, Walz DT, Finkelstein AE. Superoxide radical production by human leukocytes exposed to immune complexes: inhibitory action of gold compounds. Inflammation. 1983; 7: 355-362
11. Taylor-Robinson D, Keat A. Septic and aseptic arthritis: a continuum? Baillieres Best Pract Res Clin Rheumatol. 1999; 13: 179-192
12. Gérard HC, Branigan PJ, Schumacher HR Jr, Hudson AP. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol. 1998; 25: 734-742
13. Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-Associated Reactive Arthritis: Pathogenic and Clinical Considerations. Clin Microbiol Rev. 2004; 17: 348-369 (Pubitemid 38534032)
14. Geipel U, Herrmann M. The infected implant. Part 1: bacteriology. Orthopäde. 2004; 33: 1411-1428
15. Atkins BL, Athanasou N, Deeks JJ, Crook DW, Simpson H, Peto TE, McLardy-Smith P, Berendt AR. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J Clin Microbiol. 1998; 36: 2932-2939
16. Schäfer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis. 2008; 47: 1403-1409
17. Sculco TP. The economic impact of infected joint arthroplasty. Orthopedics. 1995; 18: 871-873
18. Bayston R, Wood H. Small colony variants - are they anything to do with biofilms? In: Wimpenny J, Handley P, Gilbert P, et al., eds. Biofilms: community interactions and control. University of Cardiff: Bioline Publications; 1997: 161-165
19. Gilbert P, Allison DG. Biofilms and their resistance towards antimicrobial agents. In: Newman HN, Wilson M, eds. Dental Plaque. University of Cardiff: Bioline Publications; 1999: 125-143
20. Zimmerli W, Ochsner PE. Management of infections associated with prosthetic joints. Infection. 2003; 31: 99-108. (Pubitemid 36437724)
21. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998; 279: 1537-1541
22. AlBuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br. 2008; 90: 915-919 (Pubitemid 352009780)
23. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999; 20: 250-278
24. Esposito S, Leone S. Prosthetic joint infections: microbiology, diagnosis, management and prevention. Int J Antimicrob Agents 2008; 32: 287-293